Vect-Horus S.A.S.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Macromolecule
    • Radiopharmaceuticals, Contrast Agents
  • Biotechnology
    • Large Molecule

Other Names/Subsidiaries

  • Neurobiology Laboratory
See more in Biomedtracker

Latest on Vect-Horus S.A.S.

Scrip

Deal Watch: Lilly Will Take Over Beam’s Rights To Verve Cardiovascular Assets

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With Verve Again By Acqu

Scrip

Asia Deal Watch: Everest Licenses Asia Rights To Calliditas’ IgA Nephropathy Candidate

 
• By Ian Haydock, Jung Won Shin, Brian Yang, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Everest Picks Up Selected As